Skip to main content

Registry of Guardant360® Use and Outcomes In People With Advanced Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Registry of Guardant360® Use and Outcomes In People With Advanced Cancer

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Novel INXN-4001 Triple Effector Plasmid in Heart Failure

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Novel INXN-4001 Triple Effector Plasmid in Heart Failure

Videofluoroscopic Swallowing Study (VFSS)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Videofluoroscopic Swallowing Study (VFSS)

Boosting Primary Care Awareness and Treatment of Childhood Hypertension

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Boosting Primary Care Awareness and Treatment of Childhood Hypertension

Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries

Group Acupuncture Therapy With Modified Yoga

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Group Acupuncture Therapy With Modified Yoga

Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 93
  • Page 94
  • Page 95
  • Page 96
  • Page 97
  • Page 98
  • Page 99
  • Page 100
  • Page 101
  • …
  • Next page Next
  • Last page Last
Subscribe to